These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 1237342
1. Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats. Kelly PH. Brain Res; 1975 Dec 12; 100(1):163-9. PubMed ID: 1237342 [No Abstract] [Full Text] [Related]
2. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Castall B, Marsden CD, Naylor RJ, Pycock CJ. Brain Res; 1977 Mar 04; 123(1):89-111. PubMed ID: 300267 [Abstract] [Full Text] [Related]
3. Influence of naloxone upon apomorphine-induced rotational behavior in rats with electrolytic versus chemolytical lesions of the substantia nigra. Quock RM, Sadowski JA. Pharmacol Res Commun; 1986 Jul 04; 18(7):663-72. PubMed ID: 3763674 [Abstract] [Full Text] [Related]
4. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens. Jackson EA, Neumeyer JL, Kelly PH. Eur J Pharmacol; 1983 Jan 28; 87(1):15-23. PubMed ID: 6404639 [Abstract] [Full Text] [Related]
5. Nocturnal rotation in normal rats: correlation with amphetamine-induced rotation and effects of nigrostriatal lesions. Glick SD, Cox RD. Brain Res; 1978 Jul 07; 150(1):149-61. PubMed ID: 566609 [Abstract] [Full Text] [Related]
6. Apomorphine-induced rotation in normal rats and interaction with unilateral caudate lesions. Jerussi TP, Glick SD. Psychopharmacologia; 1975 Jul 07; 40(4):329-34. PubMed ID: 1096216 [Abstract] [Full Text] [Related]
10. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Robinson TE, Noordhoorn M, Chan EM, Mocsary Z, Camp DM, Whishaw IQ. Synapse; 1994 May 07; 17(1):16-25. PubMed ID: 8042143 [Abstract] [Full Text] [Related]
12. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei. Wolfarth S. Pol J Pharmacol Pharm; 1976 May 07; 28(5):469-93. PubMed ID: 796834 [No Abstract] [Full Text] [Related]
15. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Costall B, Marsden CD, Naylor RJ, Pycock CJ. Brain Res; 1976 Dec 10; 118(1):87-113. PubMed ID: 990957 [Abstract] [Full Text] [Related]
16. Sensitization to amphetamine and stress may involve nucleus accumbens and medial frontal cortex. Eichler AJ, Antelman SM. Brain Res; 1979 Nov 02; 176(2):412-6. PubMed ID: 574049 [No Abstract] [Full Text] [Related]
19. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour. Fuxe K, Ungerstedt U. Pharmacol Ther B; 1976 Nov 02; 2(1):41-7. PubMed ID: 817332 [No Abstract] [Full Text] [Related]